Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Authors recommend pembrolizumab, with or without chemotherapy, as first-line treatment
Only registered members have full access to PracticeUpdate content.